Literature DB >> 17996485

Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.

Stephen Y Lai1, Amy F Ziober, Megan N Lee, Noam A Cohen, Erica M Falls, Barry L Ziober.   

Abstract

The Rho family of GTPases regulates cellular adhesion and motility. Guanine nucleotide exchange factors (GEFs) in turn regulate GTPases by promoting nucleotide exchange from GDP to GTP. We have determined that GTP-bound Rac1 is elevated in invasive oral squamous cell carcinoma (OSCC) cell lines. Because of the critical role of invasion in the progression and metastasis of OSCC, we investigated if the GEF Vav2 modulated Rac1 and Cdc42 activation and thus influenced OSCC invasion. Expression levels of Vav2 did not correlate with invasion but phosphorylated or activated Vav2 was associated with the more invasive cell lines. Transfection of activated Vav2 into the immortalized keratinocyte cell line HaCat and a low-level expressing Vav2 invasive OSCC cell line resulted in increased GTP-bound Rac1 and Cdc42 and increased invasion. Thus, activation of Vav2 appears to modulate cellular invasion through specific regulation of Rac1 and Cdc42 activity in OSCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996485     DOI: 10.1016/j.oraloncology.2007.08.017

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Tyrosine 397 phosphorylation is critical for FAK-promoted Rac1 activation and invasive properties in oral squamous cell carcinoma cells.

Authors:  Ya-Wen Chiu; Li-Yin Liou; Pin-Ting Chen; Chieh-Ming Huang; Fuh-Jinn Luo; Yu-Kan Hsu; Ta-Chun Yuan
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

2.  Expression of CDC42 in cervical squamous cell carcinoma and its correlation with clinicopathologic characteristics.

Authors:  Ding Ma; Yuan Cheng; Youyi Zhang; Yanli Guo; Zijian Li; Geng Li
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

3.  Integrative network analysis reveals active microRNAs and their functions in gastric cancer.

Authors:  Chien-Wei Tseng; Chen-Ching Lin; Chiung-Nien Chen; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  BMC Syst Biol       Date:  2011-06-26

4.  Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity.

Authors:  L S Havel; E R Kline; A M Salgueiro; A I Marcus
Journal:  Oncogene       Date:  2014-05-26       Impact factor: 9.867

5.  Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ.

Authors:  YunQing Jiang; Indira Prabakaran; Fei Wan; Nandita Mitra; Dana K Furstenau; Rupert K Hung; Siyuan Cao; Paul J Zhang; Douglas L Fraker; Marina A Guvakova
Journal:  Biomark Res       Date:  2014-11-28

6.  Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma.

Authors:  Hsin-Pai Li; Hsin-Yi Huang; Yi-Ru Lai; Jing-Xuan Huang; Kai-Ping Chang; Chuen Hsueh; Yu-Sun Chang
Journal:  Oncotarget       Date:  2014-09-15

Review 7.  Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.

Authors:  Shulamit Katzav
Journal:  Oncotarget       Date:  2015-10-06

8.  Potassium-chloride cotransporter 3 interacts with Vav2 to synchronize the cell volume decrease response with cell protrusion dynamics.

Authors:  Adèle Salin-Cantegrel; Masoud Shekarabi; Sarah Rasheed; François M Charron; Janet Laganière; Rebecca Gaudet; Patrick A Dion; Jean-Yves Lapointe; Guy A Rouleau
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

9.  Paxillin kinase linker (PKL) regulates Vav2 signaling during cell spreading and migration.

Authors:  Matthew C Jones; Kazuya Machida; Bruce J Mayer; Christopher E Turner
Journal:  Mol Biol Cell       Date:  2013-04-24       Impact factor: 4.138

10.  Identification of novel genetic variants predisposing to familial oral squamous cell carcinomas.

Authors:  Yaping Huang; Jizhi Zhao; Guogen Mao; Grace Sanghee Lee; Jia Zhang; Lijun Bi; Liya Gu; Zhijie Chang; Joseph Valentino; Guo-Min Li
Journal:  Cell Discov       Date:  2019-11-26       Impact factor: 10.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.